![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 4
2017
Dreyling, M.; Hess, G. und Krekeler, G.
(2017):
Evaluation of safety, tolerability and efficacy of temsirolimus in patients (pts) with relapsed or refractory mantle cell lymphoma (rel/refr MCL) in routine clinical practice.
In: Annals of Oncology, Bd. 28
Dreyling, M.; Hess, G. und Krekeler, G.
(2017):
Evaluation of safety, tolerability and efficacy of Temsirolimus in patients (pts) with relapsed or refractory mantle cell lymphoma (rel/refr MCL) in routine clinical practice.
In: Oncology Research and Treatment, Bd. 40: S. 72
2016
Dreyling, M.; Krekeler, G.; Neuhof, A.; Woike, M.; Hess, G. und Kalanovic, D.
(2016):
Evaluation of safety, tolerability and efficacy of temsirolimus in patients (pts) with relapsed or refractory mantle cell lymphoma (rel/refr MCL) in routine clinical practice.
In: Annals of Oncology, Bd. 27
Dreyling, M.; Krekeler, G.; Neuhof, A.; Woike, M.; Hess, G. und Kalanovic, D.
(2016):
Evaluation of safety, tolerability and efficacy of Temsirolimus in patients (pts) with relapsed or refractory mantle cell lymphoma (rel/refr MCL) in routine clinical practice.
In: Oncology Research and Treatment, Bd. 39: S. 156